key: cord-0912358-pwuniomj
authors: Di Teodoro, Giovanni; Valleriani, Fabrizia; Puglia, Ilaria; Monaco, Federica; Di Pancrazio, Chiara; Luciani, Mirella; Krasteva, Ivanka; Petrini, Antonio; Marcacci, Maurilia; D’Alterio, Nicola; Curini, Valentina; Iorio, Mariangela; Migliorati, Giacomo; Di Domenico, Marco; Morelli, Daniela; Calistri, Paolo; Savini, Giovanni; Decaro, Nicola; Holmes, Edward C.; Lorusso, Alessio
title: SARS-CoV-2 replicates in respiratory ex vivo organ cultures of domestic ruminant species
date: 2020-11-24
journal: Vet Microbiol
DOI: 10.1016/j.vetmic.2020.108933
sha: a04d402f1dc6581561fbf372bbd1fc27749dfae9
doc_id: 912358
cord_uid: pwuniomj

There is strong evidence that severe acute respiratory syndrome 2 virus (SARS-CoV-2), the causative agent of the coronavirus disease 2019 (COVID-19) pandemic, originated from an animal reservoir. However, the exact mechanisms of emergence, the host species involved, and the risk to domestic and agricultural animals are largely unknown. Some domestic animal species, including cats and ferrets, have been demonstrated to be susceptible to SARS-CoV-2 infection, while others, such as pigs and chickens, are not. Importantly, the susceptibility of ruminants to SARS-CoV-2 is unknown, even though they often live in close proximity to humans. We investigated the replication and tissue tropism of two different SARS-CoV-2 isolates in the respiratory tract of three farm animal species - cattle, sheep, and pigs - using respiratory ex vivo organ cultures (EVOCs). We demonstrate that the respiratory tissues of cattle and sheep, but not of pigs, sustain viral replication in vitro of both isolates and that SARS-CoV-2 binds efficiently to ACE2-expressing cells of the respiratory tract of both ruminant species. Intriguingly, SARS-CoV-2 isolates containing an amino acid substitution at site 614 of the spike protein (mutation D614 G) replicated at higher magnitude in ex vivo tissues of both ruminant species, supporting previous results obtained using human cells. These results suggest that additional in vivo experiments involving several ruminant species are warranted to determine the potential role in the epidemiology of this virus.

Coronavirus disease 2019 (COVID-19) was recognized as a public health emergency of international concern on January 30, 2020 and acknowledged as a pandemic on March 11, 2020 . COVID-19 is caused by a novel human coronavirus (CoV) now referred to as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, species SARS-related coronavirus, Hoffmann et al., 2020; Wang et al., 2020) . It is reasonable to think that mutations in this viral protein could potentially have dramatic effects on viral pathogenesis, replication, and tropism. Analyses of over 28,000 S gene sequences in May 2020 revealed a D614G (23403A>G) amino acid substitution that was rare before March but increased in frequency as the pandemic spread, reaching over 74% of all published sequences by June 2020 (Yurkovetskiy et al., 2020). Notably, it has been proposed that D614G increases infectivity in cell assays in vitro and is proposed to enhance viral transmissibility in nature Plante et al., 2020) . The D614G substitution is accompanied by a set of mutations including 241C>T in the leader sequence, 3037C>T, and 14408C>T. While 3037C>T causes a synonymous mutation in nsp3 (F105F),

14408C>T is responsible for a substitution in the RNA primase (nsp 12, P323L) (Lorusso et al., 2020a) .

Although it is clear that SARS-CoV-2 has an animal origin, the exact mechanisms of emergence and which animals were involved in its genesis are currently unknown. A human pandemic poses also risks for domestic animals, particularly given their close contacts with humans, and they potentially act as an additional spill-over source for human infection. Previous studies have shown that SARS-CoV-2 replicates poorly in dogs, chickens and ducks, while cats, ferrets, and minks are was demonstrated that SARS-CoV-2 may efficiently bind to the ACE2 moieties of different animal species. In particular, it was suggested that the ACE2 of cattle and sheep can function as a SARS-CoV-2 receptor, while that of pigs, although structurally permissive to SARS-CoV-2 binding, is poorly expressed in the respiratory tract (Zhai et al., 2020) . The latter finding may in part explain the absence of SARS-CoV-2 clinical signs following experimental infection in pigs. Importantly, however, the susceptibility of farm animals to SARS-CoV-2 remains largely unknown as well as the effect of D614G in animals.

By utilizing SARS-CoV-2 infection of ex vivo organ cultures (EVOCs) we demonstrate here that the respiratory tissues of cattle and sheep, but not of pigs, sustain viral replication, and that SARS-CoV-

Three 12-month old pigs, three 18-month old cattle and three 10-month-old sheep were used to obtain respiratory EVOCs. Sampling was performed in accordance with internal guidelines of the slaughterhouse (Centro Carni Val Tordino, Mosciano S. Angelo, Teramo-Italy) where the animals were officially slaughtered. All animals originated from herds located in the Abruzzi region of central Italy. All procedures, including handling and processing of tissues, were performed according to the internal guidelines of the Istituto Zooprofilattico Sperimentale dell' Abruzzo e Molise (IZSAM).

Four virus isolates at low cell passage were used to infect the respiratory EVOCs: (i) SARS-CoV- Experiments with SARS-CoV-2 were performed in BSL-3 conditions as described previously (Lorusso et al., 2020b) . Both SARS-CoV-2 isolates have been isolated on VERO E6 cells (monkey kidney epithelial cells). SARS-CoV-2/IZSAM/46419 sequence differs from that of SARS-CoV-2/INMI1-Isolate/2020/Italy for 241C>T, 3037C>T, 14408C>T and 23403A>G. This latter leads to the non-synonymous mutation in the S protein encoding gene, D614G. Therefore, SARS-CoV-2/INMI1-Isolate/2020/Italy is indicated as D614 throughout the manuscript, while SARS-CoV-2/IZSAM/46419 as D614G.

Serum samples were collected from animals before tissue collection and tested for the presence of neutralizing antibodies against SuHV-1, BPIV-3, bovine coronavirus (BCoV, species 

Tracheal and lung EVOCs culture and viability were assessed as described previously ( Samples were stored at 4 °C and delivered to the laboratory.

To obtain tracheal EVOCs, the tracheal mucosa was stripped from the cartilage rings, cut in squares of about 25 mm 2 and washed with warm phosphate buffered saline (pH 7.4, PBS). Tissue samples were then transferred into 24-well plates. To obtain lung EVOCs, the main bronchus was catheterized, and the lung parenchyma embedded with 1% low gelling temperature agarose (type VII-A agarose, Sigma-Aldrich) pre-warmed at 37 °C. The lung lobe was then cooled to 4 °C for 20 min and cut into 1 mm thick slices. Lung tissue samples of 25 mm 2 were then transferred into 24-well plates. All EVOCs were cultured in an air-liquid interface system, slightly immersed in 1 ml of tissue culture media (DMEM addicted with 1% of l-glutamine, 1% of Penicillin/Streptomycin/Amphotericin B Solution, Thermo-Fisher). EVOCs were incubated at 37 °C with 5% CO2 for up to 72 h.

Tracheal and lung EVOCs were infected with 10 3 TCID50/ml of both SARS-CoV-2 isolates, BPIV-3, Francisco-CA, USA). As the adopted molecular assay detects three genes of SARS-CoV-2 genome namely ORF1ab, S and N protein encoding genes, for practical reasons, quantification has been performed only for the N protein encoding gene.

To study the ACE2 immunohistochemical expression, trachea and lung specimens of the same animals included in the study were immediately fixed in 10% neutral buffered formalin at the slaughterhouse and processed for histology. Three μm-thick sections were dewaxed, rehydrated, and incubated overnight at 4°C with a rabbit anti-ACE2 polyclonal antibody (Abcam; ab15348).

Immunoreactions were visualized using a biotin-streptavidin amplification method and 3-3′diaminobenzidine as chromogen (Dako REAL™ detection system). According to the manufacturer, this polyclonal antibody binds to human ACE2, although it is also predicted to bind to the ACE2 of cat, dog, monkey, and orangutan.

The specificity of the anti-ACE2 antibody used in this study and its capability to detect ACE2 of 

Sample sizes were calculated using the G*Power software (Heinrich-Heine Universität Düsseldorf, Germany). All statistical analyses were performed using GraphPad Prism software, version 8.4.3

(GraphPad Software Inc., San Diego, USA). Results were expressed as means ± standard deviation (SD) derived from three replicates of three independent experiments (one animal for each experiment). Multiple Student t-test were performed to compare sets of data. Differences were considered statistically significant when p value was ≤ 0.05.

All animals included in the study tested virologically negative for BPIV-3 virus, SuHV-1, BCoV, swine coronaviruses, and SARS-CoV-2 prior to the start of the EVOC experiments. In addition, their serum samples tested negative for BPIV-3, SuHV-1, BCoV, and SARS-CoV-2 by serumneutralization.

The viability of explanted respiratory tissues was confirmed by the marked replication of common 

Although the viability of swine EVOCs was confirmed by the growth of SuHV-1, both SARS-CoV-2

isolates failed to replicate in lung and tracheal EVOCs from pigs as statistically significant differences were not observed between either infectious viral titers on cells or RNA copies at 1 hpi and 72 hpi (p > 0.05) (Fig 1-2) . Differences between the two SARS-CoV-2 isolates were observed only at 24 hpi in tracheal EVOCs as D614G virus showed a slight, but statistically significant, higher number of RNA copies number.

the increase of viral titers (Fig 1) and RNA copies (Fig 2) over time. More in details, in bovine and ovine respiratory tissues, titers of both viruses were significantly higher at 72 hpi when compared to the earliest time point (p < 0.05). As for bovine tissues, viral titers of both SARS-CoV-2 isolates were higher in lung than trachea (up to 2 Log10) whereas titers of both viruses were of comparable levels in ovine tissues. An analysis of viral titers revealed that D614G replicated significantly at higher magnitude than D614 at 48 hpi (p < 0.01) and 72 hpi (p < 0.05) in bovine EVOCs. In ovine tissues, both viruses replicated at comparable levels. Quantification of RNA copies in EVOCs supernatants revealed more apparent differences between D614 and D614G. In particular, in J o u r n a l P r e -p r o o f bovine EVOCs, differences were significant at 72 hpi in both tissues, while in ovine EVOCs differences were significant at 48 and 72 hpi in trachea, 24 and 48 hpi in lung (Fig 2) .

The polyclonal antibody analysis revealed the presence of ACE2 expressing cells in the tracheal (Fig 3A, C) and bronchiolar (Fig 3B, D) epithelia of sheep and cattle. Notably, immunoreactivity was not observed in both porcine tissues (Fig 4E, F) .

The anti-ACE2 polyclonal antibody recognize bovine, ovine and swine ACE2.

Western blotting analysis revealed high intensity and specific bands of approximately 90-100 kDa (predicted molecular weight of ACE2 is 97 kDa) in bovine, ovine, and porcine kidney lysates. The predicted band was also observed in the Caco-2 cell line lysate (Fig 4) .

antigens were visualized by immunohistochemistry (IHC) in cells of the tracheal epithelia of both ruminant species (Fig 5A, E) . In lung parenchyma, SARS-CoV-2 was detected in the morphologically spindled epithelial type I pneumocytes and bronchiolar cells (Fig 5B, F ). In addition, immunoreactivity for SARS-COV-2 was observed in alveolar macrophages of bovine lung (Fig 5B) .

Immunoreactivity was not detected in swine respiratory and in mock infected EVOCs (Fig 5I, J 

In this round of experiments neither bovine nor ovine specific markers, suggestive of viral adaptation in the tested tissues, were identified in the viral genome. J o u r n a l P r e -p r o o f SARS-CoV-2 is the most recent example of an emerging zoonotic virus that has converted its 'pandemic potential' into reality (Gollakner et al., 2020) , and that likely has an origin in another mammalian species (Andersen et al., 2020) . Although SARS-CoV-2 is able to infect several animal species in close contact with humans, such as mink (Oreshkova et al., 2020) , the potential of SARS-CoV-2 to become established in other animal species is unclear.

Our results strongly suggest that in vivo experiments involving ruminant species are warranted to help determine the clinical outcome of infection in these species and their potential role as host animals. Importantly, however, EVOC experiments are only suggestive that these animal species may be susceptible to infection, and more confirmatory work is clearly warranted. More generally, our study highlights the potential for diverse animal species to play a role in the epidemiology of SARS-CoV-2 as well as the need for a One Health approach to tackle this major global problem (Lorusso et al., 2020b) . Number of RNA copies of SARS-CoV-2 in EVOCs supernatants infected with a dose of 10 3 TCID50/ml of the D614 and D614G strains increased significantly in bovine and ovine EVOCs from 1 to 72 hpi (p < 0.05). Quantification of RNA copies in EVOCs supernatants revealed more evident differences between D614 and D614G. Specifically, in bovine EVOCs, differences were significant at 72 hpi in both tissues, while in ovine EVOCs, differences were significant at 48 and 72 hpi in trachea, 24 and 

The proximal origin of SARS-CoV-2

Tropism and innate host responses of a novel avian influenza A H7N9 virus: An analysis of ex -vivo and in-vitro cultures of the human respiratory tract

Evaluation of the human adaptation of influenza A/H7N9 virus in PB2 protein using human and swine respiratory tract explant cultures

Respiratory explants as a model to investigate early events of contagious bovine pleuropneumonia infection

Replication kinetics and cellular tropism of emerging reoviruses i n sheep and swine respiratory ex vivo organ cultures

Is COVID-19 the first pandemic that evolves into a panzootic?

Infection and Pathogenesis of Canine, Equine, and Human Influenza Viruses in Canine Tracheas

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures

Novel coronavirus (COVID-19) epidemic: a veterinary perspective

A "One-Health" approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy

Acute respiratory distress syndrome

Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract

Critical assessment of an in vitro bovine respiratory organ culture system: A model of bovine herpesvirus-1 infection

SARS-CoV-2 infection in farmed minks, the Netherlands

Restored PB1-F2 in the 2009 pandemic H1N1 influenza virus has minimal effects in swine

Whole-Genome Sequence of a Suid Herpesvirus-1 Strain Isolated from the Brain of a Hunting Dog in Italy

SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study. The Lancet Microbe

Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Comparison of SARS-CoV-2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts

A pneumonia outbreak associated with a new coronavirus of probable bat origin

We gratefully thank Dr Paola Di Giuseppe (IZSAM) for support in formatting figures.J o u r n a l P r e -p r o o f

The authors declare that they have no competing interests.

Replication kinetics of common respiratory viruses, taken as positive control for EVOCs viability, in